Pfizer (PFE) Bids Farewell to Haleon with $3.3B Final Stake Sale
Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...
Fierce Pharma20h
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Pharmaceutical Technology on MSN1d
Curevo procures $110m and former-GSK exec for shingles vaccine candidate
Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
AllAfrica on MSN2d
GSK Rebrands to Haleon Kenya After Separation
UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.The rebrand comes after GSK transferred its consumer health business to Haleon to focus on ...
The Star2d
GSK is no more: Kenya welcomes Haleon
Pharmaceutical company GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya ...
Yahoo Finance13d
Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
Medical Dialogues21h
Pfizer to exit Haleon
Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...